Servotech Power Systems Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: May 23, 2025, 12:53 am

Competitors of Servotech Power Systems Ltd

All Competitor Stocks of Servotech Power Systems Ltd

Quarterly Result

Last Updated: February 28, 2025, 5:16 pm

Below is a detailed analysis of the quarterly data for Servotech Power Systems Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

• For Sales, as of Dec 2024, the value is 181.32 Cr.. The value appears to be declining and may need further review. It has decreased from 182.34 Cr. (Sep 2024) to 181.32 Cr., marking a decrease of 1.02 Cr..
• For Expenses, as of Dec 2024, the value is 164.87 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 163.43 Cr. (Sep 2024) to 164.87 Cr., marking an increase of 1.44 Cr..
• For Operating Profit, as of Dec 2024, the value is 16.45 Cr.. The value appears to be declining and may need further review. It has decreased from 18.91 Cr. (Sep 2024) to 16.45 Cr., marking a decrease of 2.46 Cr..
• For OPM %, as of Dec 2024, the value is 9.07%. The value appears to be declining and may need further review. It has decreased from 10.37% (Sep 2024) to 9.07%, marking a decrease of 1.30%.
• For Other Income, as of Dec 2024, the value is 0.53 Cr.. The value appears strong and on an upward trend. It has increased from 0.41 Cr. (Sep 2024) to 0.53 Cr., marking an increase of 0.12 Cr..
• For Interest, as of Dec 2024, the value is 2.38 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.48 Cr. (Sep 2024) to 2.38 Cr., marking a decrease of 0.10 Cr..
• For Depreciation, as of Dec 2024, the value is 1.50 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.47 Cr. (Sep 2024) to 1.50 Cr., marking an increase of 0.03 Cr..
• For Profit before tax, as of Dec 2024, the value is 13.10 Cr.. The value appears to be declining and may need further review. It has decreased from 15.37 Cr. (Sep 2024) to 13.10 Cr., marking a decrease of 2.27 Cr..
• For Tax %, as of Dec 2024, the value is 36.56%. The value appears to be increasing, which may not be favorable. It has increased from 26.02% (Sep 2024) to 36.56%, marking an increase of 10.54%.
• For Net Profit, as of Dec 2024, the value is 8.30 Cr.. The value appears to be declining and may need further review. It has decreased from 11.38 Cr. (Sep 2024) to 8.30 Cr., marking a decrease of 3.08 Cr..
• For EPS in Rs, as of Dec 2024, the value is 0.37. The value appears to be declining and may need further review. It has decreased from 0.51 (Sep 2024) to 0.37, marking a decrease of 0.14.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 5:20 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: May 13, 2025, 2:45 pm

Below is a detailed analysis of the balance sheet data for Servotech Power Systems Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 22.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 22.00 Cr..
• For Reserves, as of Mar 2025, the value is 202.00 Cr.. The value appears strong and on an upward trend. It has increased from 107.00 Cr. (Mar 2024) to 202.00 Cr., marking an increase of 95.00 Cr..
• For Borrowings, as of Mar 2025, the value is 75.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 81.00 Cr. (Mar 2024) to 75.00 Cr., marking a decrease of 6.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 85.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 49.00 Cr. (Mar 2024) to 85.00 Cr., marking an increase of 36.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 384.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 258.00 Cr. (Mar 2024) to 384.00 Cr., marking an increase of 126.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 70.00 Cr.. The value appears strong and on an upward trend. It has increased from 32.00 Cr. (Mar 2024) to 70.00 Cr., marking an increase of 38.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 14.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 14.00 Cr..
• For Investments, as of Mar 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2024) to 2.00 Cr., marking an increase of 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 313.00 Cr.. The value appears strong and on an upward trend. It has increased from 211.00 Cr. (Mar 2024) to 313.00 Cr., marking an increase of 102.00 Cr..
• For Total Assets, as of Mar 2025, the value is 384.00 Cr.. The value appears strong and on an upward trend. It has increased from 258.00 Cr. (Mar 2024) to 384.00 Cr., marking an increase of 126.00 Cr..

Notably, the Reserves (202.00 Cr.) exceed the Borrowings (75.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Servotech Power Systems Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. It has decreased from 2.00 (Mar 23) to 1.00, marking a decrease of 1.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 0.54. This value is below the healthy minimum of 5. It has decreased from 1.04 (Mar 23) to 0.54, marking a decrease of 0.50.
• For Diluted EPS (Rs.), as of Mar 24, the value is 0.55. This value is below the healthy minimum of 5. It has decreased from 1.11 (Mar 23) to 0.55, marking a decrease of 0.56.
• For Cash EPS (Rs.), as of Mar 24, the value is 0.68. This value is below the healthy minimum of 3. It has decreased from 1.24 (Mar 23) to 0.68, marking a decrease of 0.56.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 6.54. It has decreased from 7.73 (Mar 23) to 6.54, marking a decrease of 1.19.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 6.54. It has decreased from 7.73 (Mar 23) to 6.54, marking a decrease of 1.19.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 16.31. It has decreased from 26.19 (Mar 23) to 16.31, marking a decrease of 9.88.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 1.03. This value is below the healthy minimum of 2. It has decreased from 1.78 (Mar 23) to 1.03, marking a decrease of 0.75.
• For PBIT / Share (Rs.), as of Mar 24, the value is 0.89. This value is within the healthy range. It has decreased from 1.58 (Mar 23) to 0.89, marking a decrease of 0.69.
• For PBT / Share (Rs.), as of Mar 24, the value is 0.74. This value is within the healthy range. It has decreased from 1.36 (Mar 23) to 0.74, marking a decrease of 0.62.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 0.54. This value is below the healthy minimum of 2. It has decreased from 1.04 (Mar 23) to 0.54, marking a decrease of 0.50.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 0.54. This value is below the healthy minimum of 2. It has decreased from 1.04 (Mar 23) to 0.54, marking a decrease of 0.50.
• For PBDIT Margin (%), as of Mar 24, the value is 6.32. This value is below the healthy minimum of 10. It has decreased from 6.80 (Mar 23) to 6.32, marking a decrease of 0.48.
• For PBIT Margin (%), as of Mar 24, the value is 5.46. This value is below the healthy minimum of 10. It has decreased from 6.03 (Mar 23) to 5.46, marking a decrease of 0.57.
• For PBT Margin (%), as of Mar 24, the value is 4.57. This value is below the healthy minimum of 10. It has decreased from 5.18 (Mar 23) to 4.57, marking a decrease of 0.61.
• For Net Profit Margin (%), as of Mar 24, the value is 3.33. This value is below the healthy minimum of 5. It has decreased from 3.97 (Mar 23) to 3.33, marking a decrease of 0.64.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 3.32. This value is below the healthy minimum of 8. It has decreased from 3.97 (Mar 23) to 3.32, marking a decrease of 0.65.
• For Return on Networth / Equity (%), as of Mar 24, the value is 8.29. This value is below the healthy minimum of 15. It has decreased from 13.46 (Mar 23) to 8.29, marking a decrease of 5.17.
• For Return on Capital Employeed (%), as of Mar 24, the value is 11.87. This value is within the healthy range. It has decreased from 18.33 (Mar 23) to 11.87, marking a decrease of 6.46.
• For Return On Assets (%), as of Mar 24, the value is 4.25. This value is below the healthy minimum of 5. It has decreased from 6.63 (Mar 23) to 4.25, marking a decrease of 2.38.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.09. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.09.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.51. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 0.51.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.60. It has decreased from 2.17 (Mar 23) to 1.60, marking a decrease of 0.57.
• For Current Ratio (X), as of Mar 24, the value is 1.88. This value is within the healthy range. It has increased from 1.71 (Mar 23) to 1.88, marking an increase of 0.17.
• For Quick Ratio (X), as of Mar 24, the value is 1.54. This value is within the healthy range. It has increased from 1.43 (Mar 23) to 1.54, marking an increase of 0.11.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 10.10. This value exceeds the healthy maximum of 8. It has decreased from 13.66 (Mar 23) to 10.10, marking a decrease of 3.56.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 36.15. This value is within the healthy range. It has increased from 3.84 (Mar 23) to 36.15, marking an increase of 32.31.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 28.73. This value is within the healthy range. It has increased from 3.22 (Mar 23) to 28.73, marking an increase of 25.51.
• For Earning Retention Ratio (%), as of Mar 24, the value is 63.85. This value is within the healthy range. It has decreased from 96.16 (Mar 23) to 63.85, marking a decrease of 32.31.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 71.27. This value exceeds the healthy maximum of 70. It has decreased from 96.78 (Mar 23) to 71.27, marking a decrease of 25.51.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 7.08. This value is within the healthy range. It has decreased from 7.95 (Mar 23) to 7.08, marking a decrease of 0.87.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 4.74. This value is within the healthy range. It has decreased from 5.64 (Mar 23) to 4.74, marking a decrease of 0.90.
• For Enterprise Value (Cr.), as of Mar 24, the value is 1,689.75. It has increased from 408.83 (Mar 23) to 1,689.75, marking an increase of 1,280.92.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 4.78. This value exceeds the healthy maximum of 3. It has increased from 1.47 (Mar 23) to 4.78, marking an increase of 3.31.
• For EV / EBITDA (X), as of Mar 24, the value is 75.55. This value exceeds the healthy maximum of 15. It has increased from 21.58 (Mar 23) to 75.55, marking an increase of 53.97.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 4.76. This value exceeds the healthy maximum of 3. It has increased from 1.37 (Mar 23) to 4.76, marking an increase of 3.39.
• For Retention Ratios (%), as of Mar 24, the value is 63.84. This value is within the healthy range. It has decreased from 96.15 (Mar 23) to 63.84, marking a decrease of 32.31.
• For Price / BV (X), as of Mar 24, the value is 11.87. This value exceeds the healthy maximum of 3. It has increased from 4.66 (Mar 23) to 11.87, marking an increase of 7.21.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 4.76. This value exceeds the healthy maximum of 3. It has increased from 1.37 (Mar 23) to 4.76, marking an increase of 3.39.
• For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 23) to 0.01, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness